Nocutil Melt (Desmopressin)

Desmopressin, the active ingredient in Nocutil Melt, is a vasopressin analog presented as a sublingual melt for sublingual use. It is employed to control central diabetes insipidus and nocturnal enuresis in children and adults, and to reduce bleeding in patients with hemophilia A or von Willebrand disease.

GNH USA supplies Nocutil Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution to meet regulatory requirements.

Desmopressin is a synthetic vasopressin analog used to manage disorders of water balance and certain bleeding disorders. - Central diabetes insipidus: reduces polyuria by enhancing water reabsorption in the renal collecting ducts. - Nocturnal enuresis: decreases nighttime bladder emptying episodes by concentrating urine. - Hemophilia A: raises plasma factor VIII levels to improve clot formation. - Von Willebrand disease: elevates von Willebrand factor, helping control mucosal bleeding.

Desmopressin may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Hyponatremia: mild reduction in serum sodium. - Headache: transient cranial discomfort. - Nausea: occasional gastrointestinal upset. - Facial flushing: brief reddening of the skin.

Serious or Rare Side Effects: - Severe hyponatremia: can cause confusion, seizures, or coma. - Water intoxication: excessive fluid retention leading to edema. - Allergic reaction: rash, itching, or swelling.

When prescribing desmopressin, clinicians should observe several precautionary measures to minimize risk. - Assess renal function: evaluate kidney performance before initiating therapy. - Monitor serum sodium: check electrolytes regularly, especially in patients at risk of hyponatremia. - Limit fluid intake: advise patients to restrict excessive water consumption while on treatment. - Use with caution in elderly: older adults have higher susceptibility to water retention and electrolyte imbalance. - Avoid concomitant hyponatremia‑inducing drugs: review medication list for diuretics or SSRIs. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Desmopressin can interact with several medicines that affect water balance or its antidiuretic effect.

Major Interactions (Avoid): - Concomitant use with carbamazepine: may reduce desmopressin efficacy. - Co‑administration with thiazide diuretics: increases risk of hyponatremia. - Combination with selective serotonin reuptake inhibitors (SSRIs): potentiates hyponatremia.

Moderate Interactions (Monitor Closely): - NSAIDs: may enhance antidiuretic effect, requiring sodium monitoring. - Anticonvulsants such as phenobarbital: may lower plasma levels of desmopressin.